PubMed Health⌕ Search

PubMed · 6655445

A multi-centre evaluation of the FP-900 analyzing system.

Abstract

The performance of the FP-900 Analyzing system manufactured by Labsystems Oy, Helsinki, Finland, was evaluated in a multi-centre study according to the principle outlined in the 1st Draft of the Standard for Instrument Testing produced by the European Committee for Clinical Laboratory Standards (ECCLS). The FP-900 System comprises a photometer for simultaneous measurement of the absorbance in a nine-compartment cuvette block, and the accessories for handling samples (sampler, simultaneous dispensing of 9 reagent charges, incubator with thermostat and shaker, and centrifuge); the photometer function, printout of results and data processing are programmable with a microprocessor. The performance specifications given by the manufacturer were checked when appropriate. As examples of typical methodologies cholesterol was selected as an end-point absorbance method, creatinine as a fixed-time (two-point) kinetic and aspartate aminotransferase as multi-point, continuous method. The within- and between-laboratory imprecision, deviation from assigned values of commercial control sera, and carry-over were determined. The performance was compared with other analytical systems: Mark I Autoanalyzer and Hitachi 705. The cost, speed and capacity was estimated from the results of the present study. The performance of the analyser and results of applying the ECCLS Draft to actual instrument testing are discussed.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

N E Saris, M Kansanen, R Hekali, L Huurrekorpi, H Kivistö, T Lahikainen. 1983. A multi-centre evaluation of the FP-900 analyzing system.. https://doi.org/10.1515/cclm.1983.21.11.683

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Confidence intervals for multinomial logistic regression in sparse data.

Logistic regression is one of the most widely used regression models in practice, but alternatives to conventional maximum likelihood estimation methods may be more appropriate for small or sparse samples. Modification of the logistic regression score function to remove first-order bias is equivalent to penalizing the likelihood by the Jeffreys prior, and yields penalized maximum likelihood estimates (PLEs) that always exist, even in samples in which maximum likelihood estimates (MLEs) are infinite. PLEs are an attractive alternative in small-to-moderate-sized samples, and are preferred to exact conditional MLEs when there are continuous covariates. We present methods to construct confidence intervals (CI) in the penalized multinomial logistic regression model, and compare CI coverage and length for the PLE-based methods to that of conventional MLE-based methods in trinomial logistic regressions with both binary and continuous covariates. Based on simulation studies in sparse data sets, we recommend profile CIs over asymptotic Wald-type intervals for the PLEs in all cases. Furthermore, when finite sample bias and data separation are likely to occur, we prefer PLE profile CIs over MLE methods.

Aspartate Aminotransferases↗

Significance of low or normal serum gamma glutamyl transferase level in infants with idiopathic neonatal hepatitis.

INTRODUCTION: We evaluated the significance of low/normal serum gamma glutamyl transferase (GGT) level in infants with idiopathic neonatal hepatitis (INH). MATERIALS AND METHODS: A retrospective review of the hospital records of 103 infants less than 3 months of age who were diagnosed with INH between August 1991 and November 2000 was performed. Variables including age at which jaundice was noticed, age at presentation, perinatal risk factors, family history of liver disease, parental consanguinity, initial ultrasound scan, liver biopsy, laboratory values at the first visit, the peak levels of total bilirubin, aspartate aminotransferase (AST), GGT and alkaline phosphatase (ALP) in the first 3 months of follow-up and interval for normalisation of serum bilirubin and AST were compared between infants presenting with low/normal GGT ( 100 U/L). RESULTS AND DISCUSSION: Infants with low/normal GGT levels presented earlier (median 36.5 days versus 44 days; p=0.016) and had significantly higher bilirubin and AST levels at presentation (bilirubin 167.5 micromol/L versus 133 micromol/L; p<0.005 and AST 187.5 U/L versus 106 U/L; p<0.001) and at peak levels (bilirubin 170 micromol/L versus 146 micromol/L; p=0.024 and AST 210.5 U/L versus 129 U/L; p=0.001). A significant correlation was also found between GGT levels and serum albumin levels (p=0.004). Patients with low/normal GGT levels were more likely to have giant cell hepatitis on histology (p=0.015). There was no difference in time taken to recovery. CONCLUSION: Low/normal levels of GGT in INH infants may be a predictor of more severe but recoverable disease.

Aspartate Aminotransferases↗